Codrituzumab (Anti-GPC3 / Glypican-3)
A2476
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameCodrituzumab (Anti-GPC3 / Glypican-3)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionCodrituzumab is a monoclonal antibody targeting GPC3 (glypican-3) which is an oncofetal protein expressed on the cell surface of hepatocellular carcinoma (HCC). Codrituzumab induces antibody-dependent cellular cytotoxicity (ADCC) and inhibits tumor growth. MW: 150 KD.
- Storage Instruction-20°C
- UNSPSC12352203